Mirum Pharmaceuticals Completes Successful Pre-NDA Meeting with FDA for Maralixibat

Go back to Mirum Pharmaceuticals Completes Successful Pre-NDA Meeting with FDA for Maralixibat
(NASDAQ: MIRM) Delayed: 98.22 -2.39 (2.38%)
Previous Close $100.61    52 Week High
Open $102.78    52 Week Low
Day High $103.28    P/E N/A 
Day Low $97.80    EPS
Volume 441,101